Israeli Prime Minister Benjamin Netanyahu said his government would do its utmost to blunt the effect of job cuts at Teva Pharmaceutical Industries Ltd as the debt-saddled company carries out its restructuring plan.
Netanyahu and Minister of Finance Moshe Kahlon are to meet this week with Teva chief executive officer Kare Schultz to try to “minimize the blow to workers,” according to an e-mailed statement from the prime minister’s office.
Netanyahu said he would do everything possible to prevent the closure of local plants and ensure that Teva, based near Tel Aviv, “will remain an Israeli company.”
Netanyahu stepped in after Schultz announced plans last week to slash 25 percent of Teva’s workforce and suspend dividends, aiming to cut US$3 billion in costs and whittle down a debt pile more than twice the size of Teva’s market capitalization.
Striking workers on Sunday idled Israel’s international airport, government offices, banks and stock market for half a day, pressing to scale back Teva’s plan to cut 14,000 jobs, including 1,700 in Israel.
The protesting employees tied up morning rush-hour traffic and burned tires outside a Jerusalem factory, while some barricaded themselves inside. Hundreds of Teva employees marched to Netanyahu’s office before Cabinet members arrived for their weekly meeting.
The government is considering a grant to Teva that would enable it to cut fewer Israeli jobs, the Haaretz newspaper said, without saying how it got the information.
In Israel, Teva had been viewed with pride for decades as the nation’s only corporate giant by global standards, with so many Israelis owning Teva shares that it is referred to as “the people’s stock.” One of the world’s biggest generic drugmakers, it is also one of Israel’s biggest employers. As a symbol of Israel’s entrepreneurial spirit, its meltdown is therefore seen as much more than just another failed business.
A walkout that the Histadrut labor federation called on Sunday in solidarity with Teva employees lasted until noon.
“Our factory is bleeding and the situation is bleak,” Teva union leader Itzik Ben-Simon told Israel Radio.
The company is monitoring the protests and seeking to minimize any effect on operations, spokesman Yonatan Beker said by telephone.
“Teva’s supply chain is evaluating its product supplies and production alternatives for all its products at any disrupted facilities, and will update its customers directly on the matter,” the company said in a statement.
Teva has been struggling since it paid almost US$41 billion last year to acquire Allergan PLC’s generics unit, a deal that failed to yield the anticipated sales boost. Compounding the problem is the loss of its monopoly on Copaxone, a multiple-sclerosis drug that at one point generated half of Teva’s profits.
Teva shares on Sunday rose as much as 2.7 percent in Tel Aviv trading, after jumping 13 percent on Thursday last week when Schultz outlined the restructuring plan. Teva’s US depositary receipts rose 10 percent on Thursday last week in New York and 8 percent the following day.
The drugmaker, whose expenses are to total US$16.1 billion this year, said most of the cost reduction is to take place next year.
It also is to record a restructuring charge of at least US$700 million, it said.
Schultz said his top priority is to bring Teva’s leverage below four times earnings before interest, taxes, depreciation and amortization by the end of 2020.
The ratio was 4.7 last quarter.
The proposals include paying down US$4 billion of bank loans within a “relatively short” period, he said.
Schultz, who was offered US$40 million in cash and stock to take the CEO job last month, swiftly instituted a management shakeup and announced plans to reorganize Teva’s generic and branded drug businesses into a single, streamlined entity.
TECH RACE: The Chinese firm showed off its new Mate XT hours after the latest iPhone launch, but its price tag and limited supply could be drawbacks China’s Huawei Technologies Co (華為) yesterday unveiled the world’s first tri-foldable phone, as it seeks to expand its lead in the world’s biggest smartphone market and steal the spotlight from Apple Inc hours after it debuted a new iPhone. The Chinese tech giant showed off its new Mate XT, which users can fold three ways like an accordion screen door, during a launch ceremony in Shenzhen. The Mate XT comes in red and black and has a 10.2-inch display screen. At 3.6mm thick, it is the world’s slimmest foldable smartphone, Huawei said. The company’s Web site showed that it has garnered more than
CROSS-STRAIT TENSIONS: The US company could switch orders from TSMC to alternative suppliers, but that would lower chip quality, CEO Jensen Huang said Nvidia Corp CEO Jensen Huang (黃仁勳), whose products have become the hottest commodity in the technology world, on Wednesday said that the scramble for a limited amount of supply has frustrated some customers and raised tensions. “The demand on it is so great, and everyone wants to be first and everyone wants to be most,” he told the audience at a Goldman Sachs Group Inc technology conference in San Francisco. “We probably have more emotional customers today. Deservedly so. It’s tense. We’re trying to do the best we can.” Huang’s company is experiencing strong demand for its latest generation of chips, called
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Vanguard International Semiconductor Corp (世界先進) and Episil Technologies Inc (漢磊) yesterday announced plans to jointly build an 8-inch fab to produce silicon carbide (SiC) chips through an equity acquisition deal. SiC chips offer higher efficiency and lower energy loss than pure silicon chips, and they are able to operate at higher temperatures. They have become crucial to the development of electric vehicles, artificial intelligence data centers, green energy storage and industrial devices. Vanguard, a contract chipmaker focused on making power management chips and driver ICs for displays, is to acquire a 13 percent stake in Episil for NT$2.48 billion (US$77.1 million).
RSS